Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease

Céline Morissette, Diane Lacombe, Xianqi Kong, Ahmed Aman, Pascale Krzywkowski, Lioudmila Rodionova, Mounia Azzi, Daniel Delorme, Barry Greenberg

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Amyloid refers to extracellular proteinaceous fibrillar tissue deposits having a unique set of morphologic, tinctorial, ultrastructural, and protein-folding characteristics (Kisilevsky, 1996). Up to now, more than 25 amyloid proteins or peptides have been identified, each being associated with one type of amyloid deposit (for a review see: Westermark et al., 2005).

Original languageEnglish (US)
Title of host publicationPharmacological Mechanisms in Alzheimer's Therapeutics
PublisherSpringer New York
Pages255-273
Number of pages19
ISBN (Electronic)9780387715223
ISBN (Print)9780387715216
DOIs
StatePublished - Jan 1 2007
Externally publishedYes

Fingerprint

Amyloidogenic Proteins
Protein Folding
Amyloid Plaques
Glycosaminoglycans
Amyloid
Alzheimer Disease
Staining and Labeling
Peptides

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Morissette, C., Lacombe, D., Kong, X., Aman, A., Krzywkowski, P., Rodionova, L., ... Greenberg, B. (2007). Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease. In Pharmacological Mechanisms in Alzheimer's Therapeutics (pp. 255-273). Springer New York. https://doi.org/10.1007/978-0-387-71522-3_16

Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease. / Morissette, Céline; Lacombe, Diane; Kong, Xianqi; Aman, Ahmed; Krzywkowski, Pascale; Rodionova, Lioudmila; Azzi, Mounia; Delorme, Daniel; Greenberg, Barry.

Pharmacological Mechanisms in Alzheimer's Therapeutics. Springer New York, 2007. p. 255-273.

Research output: Chapter in Book/Report/Conference proceedingChapter

Morissette, C, Lacombe, D, Kong, X, Aman, A, Krzywkowski, P, Rodionova, L, Azzi, M, Delorme, D & Greenberg, B 2007, Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease. in Pharmacological Mechanisms in Alzheimer's Therapeutics. Springer New York, pp. 255-273. https://doi.org/10.1007/978-0-387-71522-3_16
Morissette C, Lacombe D, Kong X, Aman A, Krzywkowski P, Rodionova L et al. Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease. In Pharmacological Mechanisms in Alzheimer's Therapeutics. Springer New York. 2007. p. 255-273 https://doi.org/10.1007/978-0-387-71522-3_16
Morissette, Céline ; Lacombe, Diane ; Kong, Xianqi ; Aman, Ahmed ; Krzywkowski, Pascale ; Rodionova, Lioudmila ; Azzi, Mounia ; Delorme, Daniel ; Greenberg, Barry. / Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease. Pharmacological Mechanisms in Alzheimer's Therapeutics. Springer New York, 2007. pp. 255-273
@inbook{53d43f2d3f534d76acbb34d7a23e0db8,
title = "Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease",
abstract = "Amyloid refers to extracellular proteinaceous fibrillar tissue deposits having a unique set of morphologic, tinctorial, ultrastructural, and protein-folding characteristics (Kisilevsky, 1996). Up to now, more than 25 amyloid proteins or peptides have been identified, each being associated with one type of amyloid deposit (for a review see: Westermark et al., 2005).",
author = "C{\'e}line Morissette and Diane Lacombe and Xianqi Kong and Ahmed Aman and Pascale Krzywkowski and Lioudmila Rodionova and Mounia Azzi and Daniel Delorme and Barry Greenberg",
year = "2007",
month = "1",
day = "1",
doi = "10.1007/978-0-387-71522-3_16",
language = "English (US)",
isbn = "9780387715216",
pages = "255--273",
booktitle = "Pharmacological Mechanisms in Alzheimer's Therapeutics",
publisher = "Springer New York",

}

TY - CHAP

T1 - Potential applications of glycosaminoglycan-related compounds in Alzheimer's disease

AU - Morissette, Céline

AU - Lacombe, Diane

AU - Kong, Xianqi

AU - Aman, Ahmed

AU - Krzywkowski, Pascale

AU - Rodionova, Lioudmila

AU - Azzi, Mounia

AU - Delorme, Daniel

AU - Greenberg, Barry

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Amyloid refers to extracellular proteinaceous fibrillar tissue deposits having a unique set of morphologic, tinctorial, ultrastructural, and protein-folding characteristics (Kisilevsky, 1996). Up to now, more than 25 amyloid proteins or peptides have been identified, each being associated with one type of amyloid deposit (for a review see: Westermark et al., 2005).

AB - Amyloid refers to extracellular proteinaceous fibrillar tissue deposits having a unique set of morphologic, tinctorial, ultrastructural, and protein-folding characteristics (Kisilevsky, 1996). Up to now, more than 25 amyloid proteins or peptides have been identified, each being associated with one type of amyloid deposit (for a review see: Westermark et al., 2005).

UR - http://www.scopus.com/inward/record.url?scp=84920130147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920130147&partnerID=8YFLogxK

U2 - 10.1007/978-0-387-71522-3_16

DO - 10.1007/978-0-387-71522-3_16

M3 - Chapter

AN - SCOPUS:84920130147

SN - 9780387715216

SP - 255

EP - 273

BT - Pharmacological Mechanisms in Alzheimer's Therapeutics

PB - Springer New York

ER -